Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia

Stopped The study was withdrawn due to lack of an appropriate patient population.

Conditions

• Bacteremia

Interventions

• DRUG: ceftobiprole medocaril

Sponsor

Basilea Pharmaceutica